Observational study on rare gynecological cancers
Prospective, Multicenter, Observational Study on Rare Gynecological Cancers
National Cancer Institute, Naples · NCT05733806
This study is trying to learn more about rare gynecological cancers to improve treatment and care for patients facing these conditions.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Sex | Female |
| Sponsor | National Cancer Institute, Naples (other) |
| Locations | 2 sites (Milan and 1 other locations) |
| Trial ID | NCT05733806 on ClinicalTrials.gov |
What this trial studies
This is a prospective, observational, multicenter registry focused on understanding the prognosis, clinical and pathological features, and management of rare gynecological tumors. The study aims to gather comprehensive data to improve the standard of care for patients with these rare malignancies. Participants will be monitored over time to assess treatment outcomes and disease progression.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with rare gynecological malignancies who can provide written informed consent and are fit for follow-up.
Not a fit: Patients who do not have rare gynecological cancers or cannot provide informed consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding and management of rare gynecological cancers, leading to improved patient outcomes.
How similar studies have performed: While there have been studies on gynecological cancers, this specific focus on rare malignancies is relatively novel and may provide new insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * rare gynecological malignancies * written informed consent * patient fit for follow-up Exclusion criteria -written informed consent not provided
Where this trial is running
Milan and 1 other locations
- Ginecologia e Ostetricia, IRCCS Ospedale San Raffaele — Milan, Italy (RECRUITING)
- IRCCS Fondazione G Pascale — Naples, Italy (RECRUITING)
Study contacts
- Principal investigator: Francesco Perrone, MD — IRCCS Fondazione G Pascale, Naples
- Study coordinator: Francesco Perrone, MD
- Email: f.perrone@istitutotumori.na.it
- Phone: 0039 081 1777 0276
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Gynecologic Cancer, rare cancers, gynecologic malignancies